SHELLEY GURLEY: Open Payments
NPI 1548389505 · OLATHE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$206 in 10 payments from 4 companies in 2025. Trend: 2023 $380 · 2024 $394 · 2025 $206
Food & beverage: $206
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $127 |
| AstraZeneca Pharmaceuticals LP | 3 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
Products named: LEQVIO, FARXIGA, Kerendia, JARDIANCE.
Industry payments across KS — which companies pay providers there.
